Excessive Platelet Sterilization Potentially Dangerous
|
By LabMedica International staff writers Posted on 22 Jun 2014 |
Chemical processes used to sterilize blood products could lead to serious health issues in transfusion recipients, according to a new study.
Researchers at Linköping University (Sweden), Université Laval (Québec, Canada), and other institutions documented the effects of pathogen reduction (PR) systems on microRNA and mRNA levels in platelets stored in the blood bank, and assessed their impact on platelet activation and function. The researchers compared the two standard PR methods, gamma irradiation alone or irradiation in combination with chemical substances that inactivate pathogenic agents by cross-linking to their nucleic acids (DNA and RNA).
The researchers found that unlike platelets subjected to gamma irradiation or stored in additive solution, the ones that were treated by the two PR systems available on the market, Intercept and Mirasol, aggregated badly, which worsened wound healing. Intercept also eradicated the nucleic acids of the platelets, causing them to become overactive and reduced in volume. Gamma radiation, on the other hand, had no damaging effects on the blood platelets. PR neither affected platelet microRNA synthesis or function, nor induced cross-linking of microRNA-sized endogenous platelet RNA species. The study was published early online on April 21, 2014, in Platelets.
“The processes that are used target the genetic material of pathogenic organisms; they were developed more than 20 years ago, before we understood the importance of the genetic material contained in platelets,” said corresponding author Patrick Provost, MD, of Université Laval. “These treatments activate blood platelets, triggering the release of RNA. The platelets end up depleted of RNA, so once transfused, they're unable to do what they normally would.”
“The problem is also that the blood platelets have nucleic acids that are very important for their wound healing abilities and communication with other cells,” added lead author clinical biochemist Abdimajid Osman, PhD, a researcher in Linköping University. “If they are eradicated it can damage the blood cells and lead to more severe bleeding for the patient. Our recommendation to blood centers is not to use any of the substances, only irradiation treatment.”
The function of platelets goes far beyond their role in blood coagulation and wound healing. They contain up to a third of the human genome in the form of ribonucleic acid (RNA), allowing them to synthesize over 1,000 proteins essential to the normal functioning of the human body. In contrast to other donated blood products, blood platelets must be stored at room temperature as they do not tolerate the cold. This entails a risk that pathogens such as bacteria and viruses develop and follow the platelets into the patient’s blood system. The consequence can be blood poisoning, in the worst case leading to death.
Related Links:
Linköping University
Université Laval
Researchers at Linköping University (Sweden), Université Laval (Québec, Canada), and other institutions documented the effects of pathogen reduction (PR) systems on microRNA and mRNA levels in platelets stored in the blood bank, and assessed their impact on platelet activation and function. The researchers compared the two standard PR methods, gamma irradiation alone or irradiation in combination with chemical substances that inactivate pathogenic agents by cross-linking to their nucleic acids (DNA and RNA).
The researchers found that unlike platelets subjected to gamma irradiation or stored in additive solution, the ones that were treated by the two PR systems available on the market, Intercept and Mirasol, aggregated badly, which worsened wound healing. Intercept also eradicated the nucleic acids of the platelets, causing them to become overactive and reduced in volume. Gamma radiation, on the other hand, had no damaging effects on the blood platelets. PR neither affected platelet microRNA synthesis or function, nor induced cross-linking of microRNA-sized endogenous platelet RNA species. The study was published early online on April 21, 2014, in Platelets.
“The processes that are used target the genetic material of pathogenic organisms; they were developed more than 20 years ago, before we understood the importance of the genetic material contained in platelets,” said corresponding author Patrick Provost, MD, of Université Laval. “These treatments activate blood platelets, triggering the release of RNA. The platelets end up depleted of RNA, so once transfused, they're unable to do what they normally would.”
“The problem is also that the blood platelets have nucleic acids that are very important for their wound healing abilities and communication with other cells,” added lead author clinical biochemist Abdimajid Osman, PhD, a researcher in Linköping University. “If they are eradicated it can damage the blood cells and lead to more severe bleeding for the patient. Our recommendation to blood centers is not to use any of the substances, only irradiation treatment.”
The function of platelets goes far beyond their role in blood coagulation and wound healing. They contain up to a third of the human genome in the form of ribonucleic acid (RNA), allowing them to synthesize over 1,000 proteins essential to the normal functioning of the human body. In contrast to other donated blood products, blood platelets must be stored at room temperature as they do not tolerate the cold. This entails a risk that pathogens such as bacteria and viruses develop and follow the platelets into the patient’s blood system. The consequence can be blood poisoning, in the worst case leading to death.
Related Links:
Linköping University
Université Laval
Latest Hematology News
- Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
- Advanced CBC-Derived Indices Integrated into Hematology Platforms
- Blood Test Enables Early Detection of Multiple Myeloma Relapse
- Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching
- Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma
- Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
- Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
- New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
- Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
- AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
- Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
- Fast and Easy Test Could Revolutionize Blood Transfusions
- High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
- AI Algorithm Effectively Distinguishes Alpha Thalassemia Subtypes
Channels
Clinical Chemistry
view channel
Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more
Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read moreMolecular Diagnostics
view channel
Sensitive Protein Marker Aids Diagnosis of Small Cell Prostate Cancer
Accurate identification of aggressive prostate cancer subtypes can be difficult when tumors lose expression of lineage markers used in routine pathology. Small cell carcinoma of the prostate, in particular,... Read more
Rapid Multiplex PCR Test Detects 11 Gastrointestinal Pathogens from Single Sample
Cepheid’s Xpert GI Panel has received CE marking under the In Vitro Diagnostic Medical Devices Regulation (IVDR) and is expected to begin shipping to countries that accept the CE mark in the coming weeks.... Read moreHematology
view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read moreImmunology
view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Immune aging is associated with weaker responses to vaccination, greater risks of infection, and higher levels of inflammation. Leveraging routinely ordered laboratory tests to quantify that responsiveness... Read more
Biomarkers and Molecular Testing Advance Precision Allergy Care
Allergic diseases often present with similar symptoms but can be driven by distinct biological mechanisms, making standardized care inefficient for many patients. Historically, individuals with pollen... Read moreMicrobiology
view channel
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
Tuberculosis is the leading cause of death among people living with HIV, and diagnosis in hospital settings remains difficult. Symptoms are often non-specific, disease can be extrapulmonary, and many patients... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreTechnology
view channel
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
Limited access to general practitioners and pathology services can delay diagnosis and monitoring for people in regional and remote communities. Rapid, on-the-spot testing can shorten turnaround times... Read more
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Latent tuberculosis remains a substantial testing workload for clinical laboratories as screening programs expand. Despite this growth, only about 40% of testing has shifted from traditional skin tests... Read moreIndustry
view channel
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Hematology services are increasingly delivered across distributed care settings, where limited staffing and complex workflows can extend turnaround times. Advanced morphology review still often depends... Read more








